Primary sclerosing cholangitis- a comprehensive review and update
Journal Title: International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP) - Year 2015, Vol 4, Issue 2
Abstract
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology characterised by inflammation and fibrosis of the biliary tree. The aim of this review is to find out the cause, symptoms, and treatment of PSC. Remissions and relapses characterize the disease course. PSC may remain quiescent for long periods of time in some patients, however, it is progressive. The mean age at diagnosis is 40 years and men are affected twice as often as women. There is a reported annual incidence of PSC of 0.9–1.31/100,000 and point prevalence of 8.5–13.6/100,000. In most, the disease progresses to cirrhosis and liver failure. Cholangiocarcinoma develops in 8–30% of patients. PSC is thought to be immune mediated and is often associated with inflammatory bowel disease, especially ulcerative colitis. The disease is diagnosed on typical cholangiographic and histological findings and after exclusion of secondary sclerosing cholangitis. Median survival has been estimated to be 12 years from diagnosis in symptomatic patients. Patients who are asymptomatic at diagnosis, the majority of whom will develop progressive disease, have a survival rate greater than 70% at 16 years after diagnosis. Liver transplantation remains the only effective therapeutic option for patients with end-stage liver disease from PSC, although high dose ursodeoxycholic acid may have a beneficial effect.
Authors and Affiliations
K. Dilip Krishnan
Keywords
Related Articles
- EP ID EP410447
- DOI -
- Views 165
- Downloads 0
In vitro studies on phytochemical analysis and antioxidant activity of Heliotropium indicum linn.
Objective The in vitro studies on phytochemical analysis and antioxidant activity of Heliotropium indicum Lin. (Boraginaceous) was evaluated by different assaying. Methods The in vitro antioxidant activity was evaluated...
A review of newer therapy in dengue fever
Dengue is a viral disease that at present affects an enormous number of people in over 125 countries and is conscientious for a sizable number of deaths. There is no antiviral chemotherapy or vaccine for dengue virus and...
Screening models for Anti-Amnesic activity evaluation: A Review
Alzheimer's disease is the most common form of dementia. The disease gets worse as it develops - it is a progressive disease. There is no current cure for Alzheimer's, although there are ways of slowing down its advance...
Biochemical screening of dengue fever
Dengue virus infection is a serious health problem infecting 2.5 billion people worldwide. Dengue virus belongs to family Flaviviridae, having four serotypes that spread by the bite of infected Aedesmosquitoes. It cause...
A new looming of Middle East respiratory syndrome coronavirus MERSCoV
Middle East Respiratory Syndrome Coronavirus is the species of genus Beta Coronavirus. A novel human coronaviruses are single-stranded RNA. They are distinct from SARS and common cold viruses. First case of MERS-CoV was...